Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Top Cited Papers
- 1 February 2009
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 15 (2) , 79-80
- https://doi.org/10.1016/j.ccr.2009.01.009
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 10 references indexed in Scilit:
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated TumorigenesisCancer Cell, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant miceJournal of Clinical Investigation, 2008
- Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience, 2007
- Significance of interleukin-6 (IL-6) in breast cancer (review)Breast Cancer Research and Treatment, 2006
- IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical HepatocarcinogenesisPublished by Elsevier ,2005
- Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesisJournal of Clinical Investigation, 2004
- IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated CancerCell, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Principles of interleukin (IL)-6-type cytokine signalling and its regulationBiochemical Journal, 2003